{"id":"https://openalex.org/W2989683552","doi":"https://doi.org/10.6004/jnccn.2019.5030","title":"Management of Recurrent Acute Lymphoblastic Leukemia With T-Cell Engagement: CAR T, BiTEs, and Beyond","display_name":"Management of Recurrent Acute Lymphoblastic Leukemia With T-Cell Engagement: CAR T, BiTEs, and Beyond","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2989683552","doi":"https://doi.org/10.6004/jnccn.2019.5030","mag":"2989683552","pmid":"https://pubmed.ncbi.nlm.nih.gov/31766014"},"language":"en","primary_location":{"id":"doi:10.6004/jnccn.2019.5030","doi":"https://doi.org/10.6004/jnccn.2019.5030","is_oa":true,"landing_page_url":"https://doi.org/10.6004/jnccn.2019.5030","pdf_url":"https://jnccn.org/downloadpdf/journals/jnccn/17/11.5/article-p1448.pdf","source":{"id":"https://openalex.org/S935620192","display_name":"Journal of the National Comprehensive Cancer Network","issn_l":"1540-1405","issn":["1540-1405","1540-1413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4324004213","host_organization_name":"National Comprehensive Cancer","host_organization_lineage":["https://openalex.org/P4324004213"],"host_organization_lineage_names":["National Comprehensive Cancer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jnccn.org/downloadpdf/journals/jnccn/17/11.5/article-p1448.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101838284","display_name":"Jae H. Park","orcid":"https://orcid.org/0000-0002-2903-5130","observed_orcids":["https://orcid.org/0000-0002-2903-5130","https://orcid.org/0009-0003-2678-9513"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4405261804","display_name":"Kite Pharma (United States)","ror":"https://ror.org/05waa9105","country_code":"US","type":"company","lineage":["https://openalex.org/I4405261804"]},{"id":"https://openalex.org/I4405280080","display_name":"Juno Therapeutics (United States)","ror":"https://ror.org/02dq5dx40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4405280080"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jae Park","raw_affiliation_strings":["Amgen Inc., AstraZeneca Pharmaceuticals LP,","GlaxoSmithKline, Incyte Corporation, Kite Pharma, Novartis Pharmaceuticals Corporation, Allogene Therapeutics, Autolus Therapeutics plc, and Takeda Pharmaceuticals North America, Inc","MD, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065","from Amgen Inc., Genentech, Inc., Incyte Corporation, Juno Therapeutics, Inc., Kite Pharma, Novartis Pharmaceuticals Corporation, and Servier;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., AstraZeneca Pharmaceuticals LP,","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline, Incyte Corporation, Kite Pharma, Novartis Pharmaceuticals Corporation, Allogene Therapeutics, Autolus Therapeutics plc, and Takeda Pharmaceuticals North America, Inc","institution_ids":["https://openalex.org/I4405261804"]},{"raw_affiliation_string":"MD, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"from Amgen Inc., Genentech, Inc., Incyte Corporation, Juno Therapeutics, Inc., Kite Pharma, Novartis Pharmaceuticals Corporation, and Servier;","institution_ids":["https://openalex.org/I4405280080"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5101838284"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4405261804","https://openalex.org/I4405280080"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20556467,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"11.5","first_page":"1448","last_page":"1450"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9140999913215637,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.08169999718666077,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-acute-lymphoblastic-leukemia","display_name":"relapsed/refractory acute lymphoblastic leukemia","score":0.9490000009536743},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.8539999723434448},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9470000267028809},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.753000020980835},{"id":"https://openalex.org/keywords/cd22","display_name":"CD22","score":0.9919999837875366},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.9210000038146973},{"id":"https://openalex.org/keywords/inotuzumab-ozogamicin","display_name":"inotuzumab ozogamicin","score":1.0},{"id":"https://openalex.org/keywords/adult-acute-lymphoblastic-leukemia","display_name":"adult acute lymphoblastic leukemia","score":0.5809999704360962},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.967631459236145},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.924622654914856},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.5751539468765259},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5593501925468445},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5398129820823669},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5001506805419922},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47372403740882874},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.47162914276123047},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.43548089265823364},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.43377789855003357},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4137760102748871},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.41057854890823364},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36483103036880493},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.21128153800964355},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.11153081059455872},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.6004/jnccn.2019.5030","doi":"https://doi.org/10.6004/jnccn.2019.5030","is_oa":true,"landing_page_url":"https://doi.org/10.6004/jnccn.2019.5030","pdf_url":"https://jnccn.org/downloadpdf/journals/jnccn/17/11.5/article-p1448.pdf","source":{"id":"https://openalex.org/S935620192","display_name":"Journal of the National Comprehensive Cancer Network","issn_l":"1540-1405","issn":["1540-1405","1540-1413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4324004213","host_organization_name":"National Comprehensive Cancer","host_organization_lineage":["https://openalex.org/P4324004213"],"host_organization_lineage_names":["National Comprehensive Cancer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network","raw_type":"journal-article"},{"id":"pmid:31766014","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31766014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network : JNCCN","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.6004/jnccn.2019.5030","doi":"https://doi.org/10.6004/jnccn.2019.5030","is_oa":true,"landing_page_url":"https://doi.org/10.6004/jnccn.2019.5030","pdf_url":"https://jnccn.org/downloadpdf/journals/jnccn/17/11.5/article-p1448.pdf","source":{"id":"https://openalex.org/S935620192","display_name":"Journal of the National Comprehensive Cancer Network","issn_l":"1540-1405","issn":["1540-1405","1540-1413"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4324004213","host_organization_name":"National Comprehensive Cancer","host_organization_lineage":["https://openalex.org/P4324004213"],"host_organization_lineage_names":["National Comprehensive Cancer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Comprehensive Cancer Network","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2989683552.pdf","grobid_xml":"https://content.openalex.org/works/W2989683552.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2419639370","https://openalex.org/W2591709377","https://openalex.org/W2787145330","https://openalex.org/W2787301955","https://openalex.org/W2787621143","https://openalex.org/W2905654455"],"related_works":["https://openalex.org/W4312620149","https://openalex.org/W7212215027","https://openalex.org/W2130338247","https://openalex.org/W2944875789","https://openalex.org/W2800550514","https://openalex.org/W4287623522","https://openalex.org/W7153046523","https://openalex.org/W2623001916","https://openalex.org/W4388040980","https://openalex.org/W4402903193"],"abstract_inverted_index":{"Immunotherapies":[0],"targeting":[1],"CD19":[2],"(blinatumomab)":[3],"and":[4,14,26,76],"CD22":[5],"(inotuzumab":[6],"ozogamicin)":[7],"have":[8],"demonstrated":[9],"higher":[10],"complete":[11],"response":[12],"rates":[13],"improved":[15],"survival":[16],"compared":[17],"with":[18,47,83],"chemotherapy":[19],"in":[20,32,74],"relapsed/refractory":[21,84],"acute":[22],"lymphoblastic":[23],"leukemia":[24],"(ALL),":[25],"are":[27],"now":[28],"standard":[29],"of":[30,42,71],"care":[31],"the":[33,55],"relapsed":[34],"setting.":[35],"However,":[36],"most":[37],"adult":[38],"patients":[39],"still":[40],"die":[41],"ALL":[43,75],"despite":[44],"these":[45],"therapies,":[46],"or":[48],"without":[49],"hematopoietic":[50],"stem":[51],"cell":[52],"transplant.":[53],"At":[54],"NCCN":[56],"2019":[57],"Annual":[58],"Congress:":[59],"Hematologic":[60],"Malignancies,":[61],"Dr.":[62],"Jae":[63],"Park":[64],"summarized":[65],"clinical":[66],"data":[67],"from":[68],"key":[69],"trials":[70],"novel":[72],"immunotherapies":[73],"reviewed":[77],"evidence-based":[78],"treatment":[79],"approaches":[80],"for":[81],"adults":[82],"B-cell":[85],"ALL.":[86]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-12-05T00:00:00"}